Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fidget Spinner Rapidly Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 16 Jun 2020
More than half of all women experience at least one episode of urinary tract infection (UTI) in their lifetime, with men also facing increasing risks of infection as they age. Current detection of UTIs relies on patients reporting symptoms followed by a laboratory culture of the urine for known bacterial culprits, which typically takes a few days.

Doctors tend to prescribe antibiotics to suppress any suspect cases of UTI before they get the test results, contributing to the increasing problem of antibiotic resistance. Dipstick tests that reduce the time taken for diagnoses come with a high chance for false positives. The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate.

A multidisciplinary and international team of scientists led by the Ulsan National Institute of Science and Technology (Ulsan, Republic of Korea) developed a fidget spinner-based device to detect UTIs from urine samples. The device was field tested on 39 patients in Tiruchirappalli, India who would have all been given antibiotics based on their symptoms alone. The team reported 59% of the patients were found to be over/under-treated with antibiotics, something that can be rectified using this novel device.

The custom-made fidget spinner rapidly concentrates pathogens in 1-mL samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. The test of the rectangular device with one or two nudges spins for a long time pushing any bacteria onto a membrane. This is then dyed, with a color change visible to the naked eye in less than one hour, which indicates the amount of bacterial load.

The device enabled the on-site detection of infection with the naked eye within 50 minutes in urine samples from the patients suspected of having a urinary tract infection. The team also showed that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 minutes.

Another test gave a preliminary indication of the presence of antibiotic resistance. By testing the spun samples treated with different drugs and comparing them to untreated samples, the team was able to quickly make a decision on which antibiotic might work best to treat the UTI. While this does not compare to laboratory based tests for microbial resistance, it is still a useful add-on for resource poor settings that do not typically test for resistance.

The authors concluded that the test can be performed by novices and that there is no extensive training that is required to learn how to spin the device and read the results. The ease-of-use, low price point, availability of quick results, and immediate benefits such as reduction in prescription of antibiotics, makes the new spinner an attractive alternative for diagnosing UTIs. The study was published on May 18, 2020 in the journal Nature Biomedical Engineering.

Related Links:
Ulsan National Institute of Science and Technology


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Multi-Function Pipetting Platform
apricot PP5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.